IRAK1 and non-small cell lung carcinoma: MiR-146a-5p demonstrated its protective effects against tumorigenesis and development of diverse neoplasms, including non-small cell lung cancer (NSCLC) by down-regulating the IRAK1 (IL-1 receptor-associated kinase 1) and TRAF6 (TNF receptor-associated factor 6) expression [243].